Ranolazine Versus Allopurinol for Eligible Symptomatic Patients With a History of Angioplasty: Comparative Efficacy Study

Ranolazine Versus Allopurinol for Eligible Symptomatic Patients With a History of Angioplasty: Comparative Efficacy Study

BackgroundRecurrent angina, which is defined as a return of chest pain or chest discomfort, occurs in many patients undergoing coronary interventions. ObjectiveThis study aims to compare the antianginal efficacy of ranolazine versus allopurinol for eligible sympto...

Full description

Bibliographic Details
Main Authors: Reza Rahmani, Ehsan Moradi Farsani, Sima Bahrami
Format: Article
Language:English
Published: JMIR Publications 2022-08-01
Series:Interactive Journal of Medical Research
Online Access:https://www.i-jmr.org/2022/2/e39778

Internet

https://www.i-jmr.org/2022/2/e39778

Similar Items